Ways and Means Committee, Energy and Commerce Committee
Introduced
In Committee
On Floor
Passed Chamber
Enacted
This legislation aims to reverse specific amendments made by Public Law 119-21 concerning healthcare policy. It proposes to repeal changes related to Medicaid cost-sharing requirements , effectively restoring the prior rules for patient contributions under the Medicaid program and rescinding associated appropriations. Furthermore, the bill seeks to eliminate modifications to the exclusion for orphan drugs within the Medicare Drug Price Negotiation Program. By repealing these sections, the legislation intends for the relevant titles of the Social Security Act to be applied as if the recent amendments had never been enacted, thereby reinstating previous provisions for these drug categories.
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
This legislation aims to reverse specific amendments made by Public Law 119-21 concerning healthcare policy. It proposes to repeal changes related to Medicaid cost-sharing requirements , effectively restoring the prior rules for patient contributions under the Medicaid program and rescinding associated appropriations. Furthermore, the bill seeks to eliminate modifications to the exclusion for orphan drugs within the Medicare Drug Price Negotiation Program. By repealing these sections, the legislation intends for the relevant titles of the Social Security Act to be applied as if the recent amendments had never been enacted, thereby reinstating previous provisions for these drug categories.
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.